04:31 PM EDT, 08/12/2026 (MT Newswires) -- Ryan Cohlhepp, Director, President and COO, on August 10, 2026, sold 18,750 shares in Bicara Therapeutics ( BCAX ) for $524,533. Following the Form 4 filing with the SEC, Cohlhepp has control over a total of 181,641 common shares of the company, with 181,641 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/2023658/000147083126000812/xslF345X05/wk-form4_1786565947.xml